Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Lucigen Continues Development of POC Platform, C Diff Test

Lucigen Continues Development of POC Platform, C Diff Test

Aug 19, 2015
|
Madeleine Johnson
Premium

NEW YORK (GenomeWeb) – Lucigen is continuing to develop a point-of-care molecular diagnostic platform with an initial assay designed for Clostridium difficile detection. The firm described the platform and preliminary results of trials using a prototype yesterday at Cambridge Healthtech Institute's Next Generation Dx Summit in Washington, DC.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Extension Call

Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.

All Along the Axon

Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.

For the Accelerator

The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.

Science Papers Describe New Cas9 Variant, Atlas of Human Metabolism

In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.

May
06
Featured Webinar

The Role of Single-Cell Functional Biomarkers in Next-Generation Cancer Therapies

Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.

What's Popular?

In PCR

  1. FDA Fleshes Out Emergency Guidance for Coronavirus Test Developers

  2. SARS-CoV-2-Related Coronaviruses Found in Pangolins

  3. Abbott POC Coronavirus Test Snares FDA Emergency Use Authorization

  4. Luminex Receives FDA Emergency Use Authorization for Coronavirus Multiplex Panel

  5. BGI Americas Gets US Emergency Use Authorization for Coronavirus Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.